Johnson Matthey PLC (LON:JMAT - Get Free Report)'s share price passed above its two hundred day moving average during trading on Tuesday . The stock has a two hundred day moving average of GBX 1,404.68 ($18.89) and traded as high as GBX 1,740 ($23.40). Johnson Matthey shares last traded at GBX 1,737 ($23.36), with a volume of 2,414,905 shares trading hands.
Johnson Matthey Stock Performance
The stock has a 50-day moving average of GBX 1,479.48 and a 200-day moving average of GBX 1,410.95. The firm has a market cap of £2.82 billion, a price-to-earnings ratio of 28.68, a price-to-earnings-growth ratio of 49,242.50 and a beta of 0.95. The company has a debt-to-equity ratio of 62.73, a quick ratio of 0.76 and a current ratio of 1.45.
Johnson Matthey (LON:JMAT - Get Free Report) last announced its earnings results on Thursday, May 22nd. The company reported GBX 149.20 ($2.01) earnings per share (EPS) for the quarter. Johnson Matthey had a return on equity of 4.49% and a net margin of 0.84%. As a group, analysts anticipate that Johnson Matthey PLC will post 173.4112903 EPS for the current fiscal year.
Johnson Matthey Increases Dividend
The company also recently announced a dividend, which was paid on Wednesday, April 16th. Investors of record on Thursday, April 10th were given a GBX 32 ($0.43) dividend. This represents a yield of 1.88%. The ex-dividend date of this dividend was Thursday, April 10th. This is a positive change from Johnson Matthey's previous dividend of $22.00. Johnson Matthey's dividend payout ratio (DPR) is currently 130.84%.
Insider Activity at Johnson Matthey
In related news, insider Liam Condon purchased 30 shares of the firm's stock in a transaction on Wednesday, April 16th. The stock was purchased at an average cost of GBX 1,200 ($16.14) per share, for a total transaction of £360 ($484.13). In the last quarter, insiders have bought 62 shares of company stock valued at $84,978. 0.61% of the stock is owned by insiders.
Johnson Matthey Company Profile
(
Get Free Report)
Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers' products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet's natural resources.
Featured Articles
Before you consider Johnson Matthey, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Johnson Matthey wasn't on the list.
While Johnson Matthey currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for July 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
